Mihos, C. G., Guigui, S. A., Horvath, S. A., Venkataraman, P., Fernandez, R., & Elajami, T. K. (2024). Presence of Apical Aneurysm and Its Impact on Left Ventricular Mechanics and Mechano‐Energetic Coupling in Patients With Apical Hypertrophic Cardiomyopathy. Echocardiography, 41(11). Portico. https://doi.org/10.1111/echo.15938

Lumish, H. S., Harano, N., Liang, L. W., Hasegawa, K., Maurer, M. S., Tower-Rader, A., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2024). Prediction of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy using plasma proteomics profiling. Europace, 26(11). https://doi.org/10.1093/europace/euae267

Lumish, H. S., Sherrid, M. V., Janssen, P. M. L., Ferrari, G., Hasegawa, K., Castillero, E., Adlestein, E., Swistel, D. G., Topkara, V. K., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2024). Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 84(20), 1999–2011. https://doi.org/10.1016/j.jacc.2024.07.043

Chan, R. H., van der Wal, L., Liberato, G., Rowin, E., Soslow, J., Maskatia, S., Chan, S., Shah, A., Fogel, M., Hernandez, L., Anwar, S., Voges, I., Carlsson, M., Buddhe, S., Laser, K. T., Greil, G., Valsangiacomo-Buechel, E., Olivotto, I., Wong, D., … Grosse-Wortmann, L. (2024). Myocardial Scarring and Sudden Cardiac Death in Young Patients With Hypertrophic Cardiomyopathy. JAMA Cardiology, 9(11), 1001. https://doi.org/10.1001/jamacardio.2024.2824

Ta, S., Li, J., Hsi, D. H., Hu, R., Lei, C., Shan, B., Li, W., Wang, J., Wang, B., Kang, N., Li, X., Liu, J., Qi, C., Huang, J., Han, Y., Ruan, F., Zhang, J., & Liu, L. (2024). Percutaneous intramyocardial septal radiofrequency ablation after 5-year follow-up. Heart, 110(11), 792–799. https://doi.org/10.1136/heartjnl-2023-323606

LEE, C., LIANG, L. W., HASEGAWA, K., MAURER, M. S., TOWER-RADER, A., FIFER, M. A., REILLY, M., & SHIMADA, Y. J. (2024). Signaling Pathways Associated With Prior Cardiovascular Events in Hypertrophic Cardiomyopathy. Journal of Cardiac Failure, 30(3), 462–472. https://doi.org/10.1016/j.cardfail.2023.07.010

Akita, K., Hasegawa, K., Fifer, M. A., Tower-Rader, A., Jung, J., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2024). Prediction of cardiac death in patients with hypertrophic cardiomyopathy using plasma adipokine levels. Nutrition, Metabolism and Cardiovascular Diseases, 34(6), 1352–1360. https://doi.org/10.1016/j.numecd.2024.01.017

Lumish, H. S., Liang, L. W., Hasegawa, K., Maurer, M. S., Fifer, M. A., Reilly, M. P., & Shimada, Y. J. (2023). Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics. Heart, 109(24), 1837–1843. https://doi.org/10.1136/heartjnl-2023-322644

Gjergjindreaj, M., Escolar, E., Papadopoulos, K., & Mihos, C. G. (2023). Assessment of left ventricular global longitudinal strain in patients with hypertrophic cardiomyopathy and coronary artery disease. The International Journal of Cardiovascular Imaging, 40(2), 361–372. https://doi.org/10.1007/s10554-023-02994-9

Liang, L. W., Lumish, H. S., Sewanan, L. R., Shimada, Y. J., Maurer, M. S., Weiner, S. D., Sayer, G., Uriel, N., & Clerkin, K. J. (2023). Advanced Heart Failure Therapies for Hypertrophic Cardiomyopathy. JACC: Heart Failure, 11(11), 1473–1480. https://doi.org/10.1016/j.jchf.2023.07.004

Kirmani, S., Woodard, P. K., Shi, L., Hamza, T. H., Canter, C. E., Colan, S. D., Pahl, E., Towbin, J. A., Webber, S. A., Rossano, J. W., Everitt, M. D., Molina, K. M., Kantor, P. F., Jefferies, J. L., Feingold, B., Addonizio, L. J., Ware, S. M., Chung, W. K., Ballweg, J. A., … Lipshultz, S. E. (2023). Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy. American Heart Journal, 264, 153–162. https://doi.org/10.1016/j.ahj.2023.06.005

Miyashita, S., Akita, K., Zhao, Y., Hasegawa, K., Maurer, M. S., Weiner, S. D., Reilly, M. P., Takayama, H., & Shimada, Y. J. (2023). Effects of bariatric surgery on cardiovascular‐related acute care use in patients with hypertrophic cardiomyopathy. ESC Heart Failure, 10(4), 2438–2446. Portico. https://doi.org/10.1002/ehf2.14414

Arabadjian, M., Nicolas, B., Montgomery, S., Pleasure, M., Collins, M., Reuter, M., Massera, D., Shimbo, D., & Sherrid, M. (2023). Clinical course and outcomes in adults with co-occurring hypertrophic cardiomyopathy and hypertension: a scoping review protocol. BMJ Open, 13(7), e075087. https://doi.org/10.1136/bmjopen-2023-075087

Liang, L. W., Hasegawa, K., Maurer, M. S., Reilly, M. P., Fifer, M. A., & Shimada, Y. J. (2023). Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways. Circulation: Heart Failure, 16(6). https://doi.org/10.1161/circheartfailure.122.010010

Mihos, C. G., Escolar, E., & Fernandez, R. (2023). Right ventricular hypertrophy in apical hypertrophic cardiomyopathy. Echocardiography, 40(6), 515–523. Portico. https://doi.org/10.1111/echo.15588

Abrams, M., Magun, E., & DeFilippis, E. M. (2023). Considerations for specific cardiomyopathies during pregnancy. Current Opinion in Cardiology, 38(3), 233–240. https://doi.org/10.1097/hco.0000000000001033

Hussey, P. T., Hussey, H., Egbaria, J., Landau, R., & Townsley, M. M. (2023). A Case Report of Spinal Anesthesia for Cerclage Placement in the Setting of Severe Hypertrophic Obstructive Cardiomyopathy. A&A Practice, 17(4), e01675. https://doi.org/10.1213/xaa.0000000000001675

Lynch, A., Tatangelo, M., Ahuja, S., Steve Fan, C.-P., Min, S., Lafreniere-Roula, M., Papaz, T., Zhou, V., Armstrong, K., Aziz, P. F., Benson, L. N., Butts, R., Dragulescu, A., Gardin, L., Godown, J., Jeewa, A., Kantor, P. F., Kaufman, B. D., Lal, A. K., … Mital, S. (2023). Risk of Sudden Death in Patients With RASopathy Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 81(11), 1035–1045. https://doi.org/10.1016/j.jacc.2023.01.012

Ojha, U., Parikh, M., & Patel, V. (2023). Percutaneous Approach for Reducing Outflow Tract Obstruction in Hypertrophic Obstructive Cardiomyopathy. Future Cardiology, 19(4), 203–210. https://doi.org/10.2217/fca-2022-0098

Wheeler, M. T., Olivotto, I., Elliott, P. M., Saberi, S., Owens, A. T., Maurer, M. S., Masri, A., Sehnert, A. J., Edelberg, J. M., Chen, Y.-M., Florea, V., Malhotra, R., Wang, A., Oręziak, A., & Myers, J. (2023). Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption. JAMA Cardiology, 8(3), 240. https://doi.org/10.1001/jamacardio.2022.5099

Yokoyama, Y., Shimoda, T., Shimada, Y. J., Shimamura, J., Akita, K., Yasuda, R., Takayama, H., & Kuno, T. (2023). Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis. European Journal of Cardio-Thoracic Surgery, 63(3). https://doi.org/10.1093/ejcts/ezad043

Conway, J., Min, S., Villa, C., Weintraub, R. G., Nakano, S., Godown, J., Tatangelo, M., Armstrong, K., Richmond, M., Kaufman, B., Lal, A. K., Balaji, S., Power, A., Baez Hernandez, N., Gardin, L., Kantor, P. F., Parent, J. J., Aziz, P. F., Jefferies, J. L., … Mital, S. (2023). The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Circulation, 147(9), 718–727. https://doi.org/10.1161/circulationaha.122.062699

Li, J., Zhang, J., Shi, Y., Sievert, H., Taub, C. C., Bertog, S., Ta, S., Changhui, L., Senser, E., Wang, J., Hu, R., Huang, J., Ruan, F., Han, Y., Li, X., Wang, B., Zhao, X., Liu, J., Hsi, D. H., & Liu, L. (2022). Myocardial mechanics of percutaneous intramyocardial septal radiofrequency ablation. Heart, 109(4), 289–296. https://doi.org/10.1136/heartjnl-2022-321597

Shimada, Y. J., Raita, Y., Liang, L. W., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2022). Prediction of Major Adverse Cardiovascular Events in Patients With Hypertrophic Cardiomyopathy Using Proteomics Profiling. Circulation: Genomic and Precision Medicine, 15(6). https://doi.org/10.1161/circgen.121.003546

Liang, L. W., Raita, Y., Hasegawa, K., Fifer, M. A., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2022). Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy. Heart, 108(22), 1807–1814. https://doi.org/10.1136/heartjnl-2021-320729

Akita, K., Suwa, K., Iguchi, K., Ushio, T., & Maekawa, Y. (2022). Mitral chordal rupture in obstructive hypertrophic cardiomyopathy visualized using four-dimensional flow cardiac magnetic resonance imaging. European Heart Journal - Cardiovascular Imaging, 23(11), e496–e496. https://doi.org/10.1093/ehjci/jeac158

Zhou, M., Ta, S., Hahn, R. T., Hsi, D. H., Leon, M. B., Hu, R., Zhang, J., Zuo, L., Li, J., Wang, J., Wang, B., Zhu, X., Liu, J., Han, Y., Li, X., Xu, B., Zhang, L., Hou, L., Han, C., … Liu, L. (2022). Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy. JAMA Cardiology, 7(5), 529. https://doi.org/10.1001/jamacardio.2022.0259